SI-BONE Inc
(FRA:2K3)
€
13.4
0.2 (1.5%)
Market Cap: 571.51 Mil
Enterprise Value: 463.38 Mil
PE Ratio: 0
PB Ratio: 3.58
GF Score: 63/100 SI-BONE Inc at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019 / 08:05PM GMT
Release Date Price:
€16.71
(-1.24%)
David Ryan Lewis
Morgan Stanley, Research Division - MD
All right. Well, let's get going here as we wrap out Day 2. This is David Lewis, medical device analyst from Morgan Stanley. It's my pleasure to have with us here SI-BONE and their CEO, Jeff Dunn. I think we're just going to jump right into Q&A, Jeff, unless there's anything you want to -- we'll just fire away?
Jeffrey W. Dunn
SI-BONE, Inc. - Chairman, President & CEO
No, go ahead.
Questions & Answers
David Ryan Lewis
Morgan Stanley, Research Division - MD
Okay. I'm ready if you are. Jeff, this has been a debate on this market since the time of the IPO. And there's -- don't matter how much progress you make or how much you think about the market, how underpenetrated it is, this lingering question about is this a big market? Maybe can you tell us kind of a year post the IPO why you're so convinced this is still a large market?
Jeffrey W. Dunn
SI-BONE, Inc. - Chairman, President & CEO
Well, I
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot